Circulation of influenza virus from 2009 to 2018 in Cameroon: 10 years of surveillance data.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
14
08
2019
accepted:
12
11
2019
entrez:
4
12
2019
pubmed:
4
12
2019
medline:
26
3
2020
Statut:
epublish
Résumé
Since the recent emergence of several subtypes of influenza viruses with pandemic potentials, there has been growing interest on the control of this infection worldwide. This study aimed to describe the 10 years of influenza activity in Cameroon between January 2009 and December 2018. Respiratory samples were collected from sentinel sites responsible for influenza surveillance in Cameroon and analyzed for the presence of influenza. Globally, 9 of the 10 administrative regions of the country were represented with at least 1 year of data. A total of 11816 respiratory samples were collected and influenza virus detection rate was 24.0%. The most represented age group was the 0-1 years representing more than 40% of the collected samples and possessing the lowest proportion of influenza cases (16.2%). Meanwhile higher proportions of influenza positive cases was found in the 2-4, 5-14 and 15-49 years age group at ≥29%. Among outpatients, the frequency of influenza virus was 24.8% while in hospitalized patients, 18.7% of samples were positive for influenza virus. We noted year-round circulation of influenza virus in Cameroon with 2 peaks in activity: a major peak in the months of September to December and a minor peak in the months of March to July. Antigenic characterization of influenza isolates showed 37.5% (6/16) vaccine match between the predominant Cameroon strains and the Northern hemisphere vaccine strains with majority of vaccine match observed in influenza B/Victoria subtype (4/6; 66.7%). Data collected from this surveillance system is essential to add to global information on the spread of influenza.
Identifiants
pubmed: 31794579
doi: 10.1371/journal.pone.0225793
pii: PONE-D-19-22986
pmc: PMC6890244
doi:
Substances chimiques
Antigens, Viral
0
Influenza Vaccines
0
Types de publication
Journal Article
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0225793Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
PLoS One. 2017 Oct 31;12(10):e0186914
pubmed: 29088290
Geospat Health. 2015 Nov 04;10(2):372
pubmed: 26618318
J Infect Dis. 2012 Dec 15;206 Suppl 1:S87-93
pubmed: 23169978
Comput Math Methods Med. 2015;2015:436495
pubmed: 26664492
J Infect Dis. 2012 Dec 15;206 Suppl 1:S74-9
pubmed: 23169976
J Infect Dis. 2012 Dec 15;206 Suppl 1:S108-13
pubmed: 23169955
PLoS One. 2015 Jul 31;10(7):e0133178
pubmed: 26230666
BMC Infect Dis. 2010 Mar 08;10:56
pubmed: 20205961
PLoS One. 2016 Mar 31;11(3):e0152310
pubmed: 27031105
Bull World Health Organ. 2014 May 1;92(5):311
pubmed: 24839317
BMC Infect Dis. 2017 Dec 04;17(1):745
pubmed: 29202715
J Infect Dis. 2012 Dec 15;206 Suppl 1:S121-8
pubmed: 23169957
PLoS One. 2009 Nov 11;4(11):e7776
pubmed: 19936224
Arch Public Health. 2017 Oct 5;75:61
pubmed: 29034093
Influenza Other Respir Viruses. 2012 May;6(3):196-203
pubmed: 21955356
BMC Public Health. 2014 Sep 20;14:981
pubmed: 25239536
J Infect Dis. 2012 Dec 15;206 Suppl 1:S29-35
pubmed: 23169968
PLoS Pathog. 2013 Mar;9(3):e1003194
pubmed: 23505366